Exposure to Extreme Temperatures, Pollution Linked to MI Death
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, July 24, 2023 -- Exposure to extreme temperature events (ETEs) and fine particulate matter (PM2.5) is associated with myocardial infarction (MI) mortality, according to a study published in the July 25 issue of Circulation.
Ruijun Xu, M.D., from Sun Yat-sen University in Guangzhou, China, and colleagues conducted a case-crossover study of 202,678 MI deaths in Jiangsu province, China, from 2015 to 2020 to examine the association of exposure to ETEs and PM2.5 with MI mortality.
The researchers found that the odds ratio of MI mortality associated with heat waves and cold spells ranged from 1.18 to 1.74 and 1.04 to 1.12, respectively, using different ETE definitions. A significant association was seen for lag 01-day exposure to PM2.5 with increased odds of MI mortality, which was attenuated at higher exposures. A significant synergistic interaction was seen for heat wave and PM2.5 on MI mortality, which was higher for heat wave with greater intensities and longer durations. Up to 2.8 percent of the MI deaths were attributable to ETE and PM2.5 exposure at levels exceeding the interim target 3 value of the World Health Organization air quality guidelines (37.5 µg/m3). Women and older adults were more vulnerable to ETEs and PM2.5; there was no variation in the interactive effects of ETEs or PM2.5 on MI mortality across sex, age, or socioeconomic status.
"Our findings provide crucial evidence that mitigating exposure to ETEs and PM2.5 may be useful to prevent premature deaths from MI and highlight great public health significance to take particulate pollution into consideration when providing ETE warning services to the public," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Women, Black and Hispanic Adults Have Lower Angiography/PCI Use in NSTEMI
THURSDAY, May 16, 2024 -- Disparities are evident in the interventional management of non-ST-segment elevated myocardial infarction (NSTEMI) and in STEMI incidence and mortality...
ACC: Empagliflozin Does Not Cut Risk for Heart Failure After Acute MI
WEDNESDAY, April 10, 2024 -- Empagliflozin does not reduce the risk for first hospitalization for heart failure or death among patients at increased risk for heart failure after...
ACC: Empagliflozin Cuts Heart Failure Hospitalization Risk After AMI
MONDAY, April 8, 2024 -- For patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.